ArticleNPJ precision oncology2024

Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers.

Daniel P Nussbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.